Scientific Program

Triumph Luxury Hotel  |  Kindly stick to the presentation time

Thursday, 1st October 2026

09:00 - 10:00Opening Ceremony

Speakers: Amany Helal, Amgad Hashem, Heba El-Zawahry, Hesham El-Ghazaly, Mohamed Abd-Elmoaty Samra, Mohamed Emara, Tamer Shawky, Yasser Rouk

10:00 - 12:00Dilemmas in breast cancer management

Chairpersons: Ahmed Touny, Ashraf Selim, Azza Nasr, Ikram Hamed, Lobna Ezz-Elarab, Magda Morad, Maha El-Zaafarany, Mohamed Mahmoud, Saad Eissa, Tarek Khairy, Wahid Yousry

10:00-10:20
Futuristic Pathobiology of Breast Cancer Management
Nadia Mokhtar
10:20-10:40
Heterogeneity in pathology and patient selection in breast cancer therapy
Heba El-Zawahry
10:40-11:00
Omitting breast and axilla surgery: A new frontier for breast cancer management
Bahadir M. Gulluoglu
11:00-11:20
AI-Assisted Breast Imaging: Improving Detection and Lesion Characterization
Rasha Kamal
11:20-11:40
"Frozen section" — Can it be totally omitted in operations for breast cancer?
Sherif Naguib
11:40-12:00
HyperArc: New Technology in Stereotactic Treatment
Ahmed Amin
12:00 - 12:30  Lunch
12:30 - 03:00From early to advanced: Navigating the breast cancer Journey

Chairpersons: Amgad Shahin, Eman Eltouny, Enas Elnady, Hanan Shawky, Hannan Nassar, Khaled Nagieb, Lobna Abd-Elaziz, Marwa Nabil, Reham Safwat, Samir Eid Shehata

12:30-01:30
Optimization of neoadjuvant treatment in TNBC: Bridging the gap between efficacy and economy
Hamdy Abd-Elaziem
01:30-02:00
Metastatic Her2 +ve Breast Cancer: An Overview
Alaa Kandil
02:00-02:20
ER Low BC: Navigating treatment of the gray zone
Mohamed Awad
02:20-02:35
Role of Capivasertib in metastatic HR+ breast cancer management AstraZeneca Symposium
Mai Eissa
02:35-03:00
The role of CDK4/6i in the management of HR+/HER2- early Breast Cancer Novartis Symposium
Ibtessam Saadeldin
03:00 - 03:30  Coffee Break
03:30 - 05:30Redefining the future of advanced breast cancer

Chairpersons: Alfred Elias, Fifi Mostafa, Gehan Elsharany, Hayam Ghazy, Mohamed Nabil, Mostafa Abdelhakim, Nervana Magdy, Salem Eid, Sherin Elshorbagy, Wael Elsheshtawy

03:30-03:50
Targeting PI3K Pathway unlocking new opportunities
Hossam El-Ashtokhy
03:50-04:10
Recommendations of NGS in advanced breast cancer
Amira Diaa
04:10-04:30
Targeting TROP-2: The ADCs revolution in advanced BC
Mai Eissa
04:30-04:50
Case Discussion — Metastatic luminal HER2 neu-ve Breast Cancer
Mostafa El-Zaidy
04:50-05:10
Management of HER2-Positive Metastatic Breast Cancer: "Where do we stand in 2026? and Clinical Implications!" Roche Symposium
Emad Shash
05:10-05:30
Advancing Adjuvant Therapy in HR+HER2- EBC: Evidence, Outcomes, and Impact EVA Symposium
Eman A. Khalaf
05:30 - 07:00MDT

Moderators: Amany Helal, Maher Hassan

05:30-06:00
Inflammatory breast cancer — Rad: Lamia El Malatawy | Path: Hend El-Ghareeb | Surg: Mohamed Fawzy | Onc: Omar Reda
06:00-06:30
Recurrent DCIS — Rad: Noora El Kashef | Path: Hend El-Ghareeb | Surg: Ashraf Nagieb | Onc: Youmna Megahed
Panelists
Surgery: Anas Aburomman, Artefaa Al-Shamari, Bahadir M. Gulluoglu, Omar Z. Youssef, Roaa Attiah, Sherif Naguib
Medical Oncology: Ali Helal, Amr Sakr, Ayman Abdelsamea, Nevin Gado, Thoraia Abdelhamed
Radiology: Aml Hegazy, Eman El Bakoury, Heba Azzam, Mona Zaky, Nermeen Soliman, Omniya Mokhtar
Radiotherapy: Medhat Elsebaie, Reem Emad
Pathology: Ahmed Abdelaziz, Iman Gouda, Manal Elmahdy, Nadia Mokhtar, Shady Elia
07:00 - 08:00  Dinner